Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Improving diagnosis and treatment of attention deficits after head injury
2004-004921-89Phase 4Completed
- Sponsor
- North Bristol NHS Trust
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methylphenidate, reboxetine and modafinil in attention deficit hyperactivity disorder (ADHD) (3 arms), sponsored by North Bristol NHS Trust. Primary endpoints: Normalization of event-related brain potentials (ERPs) and Improved behavioral measures of attention. Started Feb 2005; status: completed.
02
Drugs
methylphenidatereboxetinemodafinil
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2004-004921-89.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004921-89.